Neridronate is an amino-bisphosphonate drug primarily indicated for the treatment of osteogenesis imperfecta and Paget's disease of bone, where it functions by inhibiting osteoclast-mediated bone resorption.… Read more
Neridronate is an amino-bisphosphonate drug primarily indicated for the treatment of osteogenesis imperfecta and Paget's disease of bone, where it functions by inhibiting osteoclast-mediated bone resorption. This category contains high-quality reference standards for Neridronate, along with its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. These materials are essential for pharmaceutical laboratories conducting rigorous impurity profiling, method validation, and routine quality control assessments. Analytical chemists rely on these certified reference materials to ensure the accuracy of identification and quantification processes during drug development and stability testing. By providing consistent standards for comparison, these compounds facilitate compliance with regulatory requirements for characterizing degradation products and process-related impurities throughout the manufacturing lifecycle of bisphosphonate therapeutics.